Released Mar 30, 2016, after the close
10-K filed Mar 30, 2016, 90 days after period end · 0001437749-16-028706
Q4 2015 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$1.67M$1.67M derived+75.4% vs Q4 2014+149.3% vs Q3 2015
Net Income-$606.77K-$606.77K derivedN/M vs Q4 2014N/M vs Q3 2015
EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived$1,049,818+44.7%
Operating Incomederived-$424,401N/M
Operating Cash Flowderived-$14,586,252N/M
Free Cash Flowderived-$14,587,538N/M
Margins · derived
Gross margin62.9%−13.3 pt vs Q4 2014
Operating margin-25.4%+32.0 pt vs Q4 2014
Net margin-36.3%+16.9 pt vs Q4 2014
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures | Q4 2013dderived from reported figures | Q4 2012 |
|---|---|---|---|---|
| Revenue | $1.67M | $951.70K | $327.50K | $1.94M |
| Net Income | -$606.77K | -$506.55K | -$929.19K | -$249.92K |
| EPS Diluted | — | — | — | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio Key International Inc · CIK 1019034 · Engraved from SEC EDGAR